The findings indicate that the patient exhibited leukopenia, lymphopenia, and reduced numbers of CD3, CD4, CD16/56, and CD19 cells, indicating impaired T-cell development and compromised cellular immunity. This evidence concerns the gene CD4 and lymphopenia.